A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
Clinical trial NCT00312351 · TERMINATED
Trial details
- NCT number
- NCT00312351
- Sponsor
- Eyetech Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.